LEXICON PHARMACEUTICALS, INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 26, 2014 5.25% Convertible Senior Notes due 2021Indenture • November 28th, 2014 • Lexicon Pharmaceuticals, Inc./De • Pharmaceutical preparations • New York
Contract Type FiledNovember 28th, 2014 Company Industry JurisdictionINDENTURE dated as of November 26, 2014 between Lexicon Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and Wells Fargo Bank, National Association, a national banking association, as Trustee (the “Trustee,” as more fully set forth in Section 1.01).
Solazyme, Inc. AND Wells Fargo Bank, National Association, as Trustee INDENTURE Dated as of April [ ], 2014 [ ]% Convertible Senior Subordinated Notes due 2019Indenture • March 25th, 2014 • Solazyme Inc • Industrial organic chemicals • New York
Contract Type FiledMarch 25th, 2014 Company Industry JurisdictionINDENTURE dated as of April [ ], 2014 between Solazyme, Inc., a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01) and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
TERADYNE, INC. as Issuer AND U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of April 6, 2009 4.50% Convertible Senior Notes due 2014Indenture • April 6th, 2009 • Teradyne, Inc • Instruments for meas & testing of electricity & elec signals • New York
Contract Type FiledApril 6th, 2009 Company Industry JurisdictionINDENTURE dated as of April 6, 2009 between Teradyne, Inc., a Massachusetts corporation, as issuer (hereinafter sometimes called the “Company,” as more fully set forth in Section 1.01) and U.S. Bank National Association, a national banking association, as trustee (hereinafter sometimes called the “Trustee,” as more fully set forth in Section 1.01).
SALIX PHARMACEUTICALS, LTD. as Issuer AND U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of August 22, 2008 5.5% Convertible Senior Notes due 2028Indenture • August 22nd, 2008 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledAugust 22nd, 2008 Company Industry JurisdictionINDENTURE dated as of August 22, 2008 between Salix Pharmaceuticals, Ltd., a Delaware corporation, as issuer (the “Company”) and U.S. Bank National Association, as trustee (the “Trustee”).